Abstract
Previously, Auto Mode Switch (AMS) algorithms have been used extensively to assess the frequency and pattern of atrial tachyarrhythmia (AT) or atrial fibrillation (AF) in dual-chamber pacemakers (PMs). Although these algorithms provide effective therapy in stabilizing ventricular rates during atrial arrhythmia (AA), AMS has limited diagnostic capabilities. St. Jude Medical (SJM) has introduced a new AT/AF detection algorithm in the ADx family of PMs, which is designed detect the presence of AT/AF episodes, as well as provide clinicians with enhanced long-term patient diagnostics. The AWARE trial evaluated the incidence of AT/AF and inappropriate detection of AT/AF events in patients with a history of AT or AF by analyzing AT/AF triggered electrograms (EGMs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
